PNC Financial Services Group Inc. lessened its holdings in shares of Chemed Co. (NYSE:CHE – Free Report) by 19.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,756 shares of the company’s stock after selling 675 shares during the period. PNC Financial Services Group Inc.’s holdings in Chemed were worth $1,611,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in the business. GAMMA Investing LLC acquired a new position in shares of Chemed during the fourth quarter valued at $37,000. Principal Securities Inc. acquired a new position in shares of Chemed during the fourth quarter valued at $51,000. SRS Capital Advisors Inc. lifted its stake in shares of Chemed by 110.6% during the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock valued at $58,000 after acquiring an additional 52 shares during the period. Covestor Ltd lifted its stake in shares of Chemed by 27.4% during the third quarter. Covestor Ltd now owns 144 shares of the company’s stock valued at $75,000 after acquiring an additional 31 shares during the period. Finally, Larson Financial Group LLC lifted its stake in shares of Chemed by 86.9% during the fourth quarter. Larson Financial Group LLC now owns 157 shares of the company’s stock valued at $92,000 after acquiring an additional 73 shares during the period. Institutional investors own 95.85% of the company’s stock.
Chemed Trading Up 0.0 %
NYSE:CHE opened at $555.37 on Tuesday. Chemed Co. has a 1-year low of $492.84 and a 1-year high of $654.62. The business’s 50-day moving average price is $600.87 and its two-hundred day moving average price is $595.22. The firm has a market capitalization of $8.41 billion, a price-to-earnings ratio of 29.89, a PEG ratio of 2.27 and a beta of 0.46.
Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings results on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). The business had revenue of $589.23 million for the quarter, compared to analyst estimates of $587.18 million. Chemed had a return on equity of 30.52% and a net margin of 12.36%. Sell-side analysts predict that Chemed Co. will post 21.72 earnings per share for the current year.
Chemed Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 18th. Stockholders of record on Thursday, May 30th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date is Thursday, May 30th. Chemed’s dividend payout ratio is currently 8.61%.
Wall Street Analysts Forecast Growth
CHE has been the topic of several research reports. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Royal Bank of Canada cut their price target on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 21st. Finally, Oppenheimer increased their target price on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Thursday, February 29th.
Check Out Our Latest Stock Analysis on Chemed
Insider Buying and Selling
In related news, VP Brian C. Judkins sold 11,158 shares of the stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the completion of the transaction, the vice president now directly owns 1,422 shares in the company, valued at $917,190. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Chemed news, EVP Spencer S. Lee sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the transaction, the executive vice president now directly owns 20,760 shares in the company, valued at $13,320,654. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Brian C. Judkins sold 11,158 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the transaction, the vice president now owns 1,422 shares of the company’s stock, valued at $917,190. The disclosure for this sale can be found here. Over the last three months, insiders sold 19,808 shares of company stock worth $12,454,691. 3.32% of the stock is owned by corporate insiders.
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Chemed and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
